Study Visit Month (M) and Day (D) | D0 (Enrolment) | M1 | M2 | M3 | M4 | M5 | M6 | M9 | M12 | M15 | M18 |
---|---|---|---|---|---|---|---|---|---|---|---|
Informed consent | √ |  |  |  |  |  |  |  |  |  |  |
Eligibility criteria verified | √ |  |  |  |  |  |  |  |  |  |  |
Of those eligible: | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Locator information | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Brief medical history | √ |  |  |  |  |  |  |  |  |  |  |
Risk assessment for TB | √ |  |  |  |  |  |  |  |  |  |  |
Economics questions | √ |  |  |  |  |  |  |  |  |  |  |
Stigma scale | √ |  |  |  |  |  | √ |  |  |  | √ |
Facility dispensed treatment | √ | √ | √ | √ | √ | √ |  |  |  |  |  |
Education on the medication monitor and monitor provided to patient | √ |  |  |  |  |  |  |  |  |  |  |
Medication monitor configured to have visual and audio reminders—intervention arm only | √ |  |  |  |  |  |  |  |  |  |  |
Participants’ experience using medication monitor and adherence discussion for intervention—intervention arm only |  | √ | √ | √ | √ | √ | √ |  |  |  |  |
Social harm |  |  |  |  |  |  | √ |  | (√*) |  |  |
Pre-treatment, two and five months routine specimens abstracted from record |  |  |  |  |  |  | √ |  |  |  |  |
Treatment completion history abstracted from routine records |  |  |  |  |  |  | √ |  |  |  |  |
TB Symptom screen** |  |  |  |  |  |  |  | √ | √ | √ | √ |
Research clinic visit |  |  |  |  |  |  |  | √ | √ | √ | √ |
Sputum culture and GXP | √(*) |  |  |  |  |  | √ | (√) | (√) | (√) | √ |